TScan Therapeutics, Inc.TCRXNASDAQ
Loading
Capital Expenditure Over TimeContracting
Percentile Rank17
Studio
Year-over-Year Change

Cash spent on acquiring or upgrading physical assets

Latest
$-4.41M
Near historical average
Percentile
P17
Within normal range
Streak
2 yr
Consecutive declineContracting
Average
$-4.43M
Historical baseline
PeriodValueYoY Change
TTM$-4.41M-15.2%
2024$-3.83M-21.6%
2023$-3.15M+25.5%
2022$-4.22M+57.5%
2021$-9.94M-134.6%
2020$-4.24M-239.9%
2019$-1.25M-